MEDI-FUTURE, a company specialized in Digital Mammography,
participated in the ‘Radiological Society of North America 2014 (RSNA 2014)’ in Chicago
from 30th November to 5th December, and exhibited ‘SOUL’ and ‘Brestige TOMO’, its Full-Field Digital Mammography systems
SOUL, which is developed after a several years of studies and clinical trials, is expected to open a new prospect in the field of FFDM.
With the a-Se detector and the outstanding image processing technology, SOUL provides users with high resolution images.
Users can easily and conveniently acquire and check images with an Acquisition Work Station (AWS).
Brestige TOMO, which is now under development, is a newly upgraded model of ‘Brestige’. With its ergonomic design, the convenience is enhanced, and it is a Digital Breast Tomosynthesis (DBT) system.
MammoVu, the Review Work Station (RWS), is also exhibited for this occasion.
MammoVu is software specialized in reviewing breast images, and it offers user-friendly interface.
Starting with the RSNA 2014, MEDI-FUTURE will target the North-American market after Middle East and Russia.
With its strengthened global position in the field of Digital Mammography and its outstanding technology,
MEDI-FUTURE will enter the North-American market.
Meanwhile, MEDI-FUTURE is exporting its products in the Asian, Middle-Eastern, African,
and European markets, and is first in terms of market share in Iran and Russia.
Major products are Full-Field Digital Mammography, Stereotactic Biopsy, and Review Work Station.
* This article is a english-translated version of the article from Aving.net.
(http://kr.aving.net/news/view.php?articleId=1242575)
MEDI-FUTURE is a global healthcare IT company dedicated to women's breast care.
Create Women's Health and Beauty
1505, Startower, 37, Sagimakgol-ro 62 beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do, South Korea 13211
TEL : +82-31-8018-5140
FAX : +82-31-8018-5141
E-mail : sales@medi-future.com